PetroLabs

The Modified Ames Test was developed by Mobil Oil Corporation scientists in 1983 as a screening assay for the dermal carcinogenicity of petroleum oils. The test has become the most widely used short-term biological assay in the petroleum industry. It was adopted in 1995 as ASTM Standard Method E 1687.

The Method IP 346 was developed by Shell scientists as a chemical screening assay for dermal carcinogenicity. Like the Modified Ames Test, it relies on the fact that the principal carcinogens in oils are PAC, and that the biologically active members of the class are readily extractable into dimethyl sulfoxide (DMSO).

In partnership with Greener Tox Solutions, Biodegradation Studies, and Microtox, Petrolabs has the expertise to provide consulting services in the arena of mutagenicity and Aquatic Toxicology Assays. Let us put our expertise to work for you designing custom solutions to meet your organization's specific needs.